EP2418490A4 - Tumormarker und verwendung davon - Google Patents

Tumormarker und verwendung davon

Info

Publication number
EP2418490A4
EP2418490A4 EP10761709A EP10761709A EP2418490A4 EP 2418490 A4 EP2418490 A4 EP 2418490A4 EP 10761709 A EP10761709 A EP 10761709A EP 10761709 A EP10761709 A EP 10761709A EP 2418490 A4 EP2418490 A4 EP 2418490A4
Authority
EP
European Patent Office
Prior art keywords
tumor marker
tumor
marker
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP10761709A
Other languages
English (en)
French (fr)
Other versions
EP2418490A1 (de
Inventor
Shingo Ichimiya
Tomoki Kikuchi
Akiko Tonooka
Noriyuki Satoh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LSIP LLC
Original Assignee
LSIP LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LSIP LLC filed Critical LSIP LLC
Publication of EP2418490A1 publication Critical patent/EP2418490A1/de
Publication of EP2418490A4 publication Critical patent/EP2418490A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/046—Thyroid disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
EP10761709A 2009-04-10 2010-04-07 Tumormarker und verwendung davon Withdrawn EP2418490A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2009095561 2009-04-10
PCT/JP2010/056293 WO2010117010A1 (ja) 2009-04-10 2010-04-07 腫瘍マーカーおよびその利用

Publications (2)

Publication Number Publication Date
EP2418490A1 EP2418490A1 (de) 2012-02-15
EP2418490A4 true EP2418490A4 (de) 2012-10-10

Family

ID=42936291

Family Applications (1)

Application Number Title Priority Date Filing Date
EP10761709A Withdrawn EP2418490A4 (de) 2009-04-10 2010-04-07 Tumormarker und verwendung davon

Country Status (5)

Country Link
US (1) US20120129168A1 (de)
EP (1) EP2418490A4 (de)
JP (1) JPWO2010117010A1 (de)
CN (1) CN102365551A (de)
WO (1) WO2010117010A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109486816B (zh) * 2018-11-08 2021-04-06 浙江大学 一种用于肿瘤治疗的多聚核苷酸及其应用
CN112824540B (zh) * 2019-11-21 2024-06-18 上海市肿瘤研究所 Snx5作为肝癌预后的生物学标志物及其应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050260664A1 (en) * 2004-05-21 2005-11-24 Shaughnessy John D Use of gene expression profiling to predict survival in cancer patient
WO2006135886A2 (en) * 2005-06-13 2006-12-21 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
WO2008057545A2 (en) * 2006-11-07 2008-05-15 The Board Of Trustees Of The University Of Arkansas Gene expression profiling based identification of genomic signatures of high-risk multiple myeloma and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1839205B (zh) * 2003-05-29 2012-05-16 千年药品公司 用于鉴定、评估、预防和治疗乳腺癌的组合物、试剂盒及方法
US20060019256A1 (en) * 2003-06-09 2006-01-26 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
US7741035B2 (en) 2004-05-21 2010-06-22 Board Of Trustees Of The University Of Arkansas Use of gene expression profiling to predict survival in cancer patient
DE102004026135A1 (de) 2004-05-25 2006-01-05 Immatics Biotechnologies Gmbh An MHC-Moleküle bindende Tumor-assoziierte Peptide

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050260664A1 (en) * 2004-05-21 2005-11-24 Shaughnessy John D Use of gene expression profiling to predict survival in cancer patient
WO2006135886A2 (en) * 2005-06-13 2006-12-21 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
WO2008057545A2 (en) * 2006-11-07 2008-05-15 The Board Of Trustees Of The University Of Arkansas Gene expression profiling based identification of genomic signatures of high-risk multiple myeloma and uses thereof

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
OTSUKI T ET AL: "SNX5, a new member of the sorting nexin family, binds to the Fanconi anemia complementation group A protein", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, vol. 265, no. 3, 30 November 1999 (1999-11-30), pages 630 - 635, XP002183684, ISSN: 0006-291X, DOI: 10.1006/BBRC.1999.1731 *
S. HARA ET AL: "The DHR1 Domain of DOCK180 Binds to SNX5 and Regulates Cation-independent Mannose 6-phosphate Receptor Transport", MOLECULAR BIOLOGY OF THE CELL, vol. 19, no. 9, 1 September 2008 (2008-09-01), pages 3823 - 3835, XP055036273, ISSN: 1059-1524, DOI: 10.1091/mbc.E08-03-0314 *
See also references of WO2010117010A1 *
SHIHOKO ARA ET AL: "Sorting nexin 5 of a new diagnostic marker of papillary thyroid carcinoma regulates Caspase-2", CANCER SCIENCE, vol. 103, no. 7, 1 July 2012 (2012-07-01), pages 1356 - 1362, XP055036265, ISSN: 1347-9032, DOI: 10.1111/j.1349-7006.2012.02296.x *

Also Published As

Publication number Publication date
JPWO2010117010A1 (ja) 2012-10-18
US20120129168A1 (en) 2012-05-24
CN102365551A (zh) 2012-02-29
EP2418490A1 (de) 2012-02-15
WO2010117010A1 (ja) 2010-10-14

Similar Documents

Publication Publication Date Title
HUS2100032I1 (hu) Helyettesített 5-fluor-1H-pirazolopiridin-származékok és alkalmazásuk
HRP20181493T1 (hr) Konjugati epsilon-polilizin i njihova primjena
HK1187049A1 (en) Bisaryl-bonded aryltriazolones and use thereof
ZA201204700B (en) Optimized endonucleases and uses thereof
GB0916099D0 (en) Skin marker
HK1186082A1 (en) Biopsy marker delivery devices and methods
GB0717101D0 (en) Tumour marker
ZA201201287B (en) Therapeutic aryl-amido-aryl compounds and their use
EP2404576A4 (de) Marker und stent
EP2399993A4 (de) Hypo-immunogenes streptavidin und seine verwendung
ZA201200888B (en) New tumor marker
EP2493917B8 (de) Brusttumormarker und deren verwendung
GB0902173D0 (en) Compounds and their use
GB0908071D0 (en) Marker
GB0905964D0 (en) Marker
EP2418490A4 (de) Tumormarker und verwendung davon
EP2298883A4 (de) Neues selektionsmarkergen und verwendung davon
GB0913300D0 (en) Therapeutic compounds and their use
GB0905231D0 (en) Compounds and their use
GB0906703D0 (en) Excipients and their use
GB201005705D0 (en) Cancer markers
GB0902013D0 (en) Novel compounds and their use

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20111011

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20120906

RIC1 Information provided on ipc code assigned before grant

Ipc: C12N 15/09 20060101ALI20120831BHEP

Ipc: G01N 33/53 20060101ALI20120831BHEP

Ipc: C12Q 1/68 20060101ALI20120831BHEP

Ipc: G01N 33/574 20060101AFI20120831BHEP

17Q First examination report despatched

Effective date: 20130617

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20140327

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20140807